Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Post by retiredcfon Dec 26, 2015 1:36pm
206 Views
Post# 24413442

Recent Comments

Recent Comments
MSL-T 2015-12-23 COMMENT James Hodgins

This is his preference in healthcare. On value versus growth, this is really a deep value kind of stock. Was trading at $3 not long ago, and thinks it could easily get back to that over the next year. Trading at about 4.5 or 5 times EBITDA.


Price:
$1.980
Subject:
SMALL & MID-CAP
Bias:
UNKNOWN
Owned:
Unknown
MSL-T 2015-12-23 HOLD Jason Donville

Looking at the P/E ratio of the 40 fastest growing Canadian companies with a market cap of more than $75 million, this company is in the cheapest quartile of that group and is trading at about 5X 2016 earnings and is below BV. Thinks it has a lot of upside.


Price:
$1.980
Subject:
GROWTH STOCKS
Bias:
OPTIMISTIC
Owned:
Yes

<< Previous
Bullboard Posts
Next >>